Simon Macdonald B.Sc (Hons), MSc, PhD 

  • Wide-ranging leadership experience of multi-disciplinary and cross-institution teams
  • Record for delivering successful collaborations
  • Exceptional ability to identify and operationalize fundable scientific opportunities
  • Has held multiple academic positions at UK/US universities 

Richard Hatley MChem, DPhil, MRSC, CChem 

  • Long track record of synthetic chemistry problem solving and medicinal chemistry expertise across numerous preclinical drug discovery programs
  • Expertise in generation of new hit chemical matter, lead identification strategies and data analysis
  • Progression of small molecules to the clinic through MPO lead optimisation
  • Co-founder of two companies, navigation of VC collaborations, experience in large pharma, academia, and smaller biotech industries 

Diane Coe B.Sc (Hons), PhD, FRSC 

  • Fulbright Scholarship Awardee and highly respected scientist serving on numerous prestigious review panels and advisory boards
  • Deep “Hit to Lead” expertise including HTS screening and DEL libraries
  • Broad experience of successfully leading Lead Optimization projects and delivering clinical candidates
  • Extensive expertise in every aspect of patent preparation – for example in collaborating with Patent Attorneys to compile new patent applications  

Andy Mason B.Sc (Hons)  

  • Extensive computational and modelling skills to accelerate lead optimization and drug discovery
  • AI-enabled drug discovery and retrosynthesis approaches
  • Peptide drug discovery and due diligence 
  • Experienced leader in GMP compliant API manufacturing